Literature DB >> 33965993

"Face mask contamination during COVID-19 pandemia. Study on patients receiving intravitreal injections".

Juan Marin-Nieto1, Carmen Reino-Perez, Genoveva Santillana-Cernuda, José Manuel Díaz-Bernal, Rafael Luque-Aranda, Ignacio García-Basterra.   

Abstract

PURPOSE: To investigate the bacterial growth in the surgical face masks used by patients who received intravitreal injections and study the effect of povidone-iodine on the periocular area (PA) of masks.
METHODS: Forty patients who attended for intravitreal injections were divided in those with less (<4h) and more (>4h) than 4 hours of mask use. Each group was divided depending on the application or not of povidone-iodine in the periocular area (PA) of the mask. Bacterial load was studied on PA and mouth area (MA) samples.
RESULTS: The bacterial load in the PA was higher in the >4h group compared with the <4h group (13.2 vs 48.75 Colony Forming Units/μL; p=0.03). The contamination in the PA significantly decreased after applying povidone-iodine in the >4h group (p=0.01). The use or not of povidone-iodine was strongly correlated to a positive culture (OR=9.0, p=0.00. CI 1.63-49.44).
CONCLUSIONS: Surgical face masks worn for more than 4 hours presents higher contamination in the PA than those with less use. Bacterial load in the PA is reduced with povidone-iodine on masks used for more than 4 hours. This contamination should be considered in the asepsis protocol of intravitreal injections.
Copyright © 2021 by Ophthalmic Communications Society, Inc.

Entities:  

Year:  2021        PMID: 33965993     DOI: 10.1097/IAE.0000000000003202

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

Review 1.  Are intravitreal injections essential during the COVID-19 pandemic? Global preferred practice patterns and practical recommendations.

Authors:  A C S Tan; R Schwartz; D Anaya; I Chatziralli; M Yuan; M V Cicinelli; L Faes; M Mustapha; N Phasukkijwatana; D Pohlmann; R Reynolds; A Rosenblatt; A Savastano; S Touhami; K Vaezi; C V Ventura; D Vogt; J Ambati; M D de Smet; A Loewenstein
Journal:  Int J Retina Vitreous       Date:  2022-06-07

2.  Safety Measures for Maintaining Low Endophthalmitis Rate after Intravitreal Anti-Vascular Endothelial Growth Factor Injection before and during the COVID-19 Pandemic.

Authors:  Koji Tanaka; Hiroyuki Shimada; Ryusaburo Mori; Yorihisa Kitagawa; Hajime Onoe; Kazuki Tamura; Hiroyuki Nakashizuka
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.241

3.  Legal obligation in the general population: face mask influence on endophthalmitis after intravitreal injection.

Authors:  Jonas Neubauer; Konstantinos Gklavas; Friederike Kortüm; Mariya Gosheva; Karl Ulrich Bartz-Schmidt; Focke Ziemssen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-08-06       Impact factor: 3.535

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.